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This study compares the timeliness of Electronic Laboratory Reporting (ELR) 
with traditional reporting. ELR has been implemented in parts of the United States, and is 
perceived to be faster than traditional reporting. Faster reporting leads to faster public 
health response to prevent outbreaks, and to reduce the burden of infectious disease in 
communities. Nevada State law requires that diseases be reported within certain time 
frames. Timeliness of laboratory reporting at the Southern Nevada Health District 
(SNHD) from 1999-2012 was assessed by analyzing cases of four common diseases in 
this retrospective secondary analysis of extant data. 
The difference in timeliness regarding public health response (for public health 
investigation response time) and the difference in timeliness for legal state reporting 
requirements between ELR and traditional reporting were evaluated using independent 
samples t-tests. A two-way analysis of variance (ANOVA) was conducted to determine 
whether each disease had interactions with report type or influence on timeliness.  
The data contained 1,082 traditional reports and 1,343 ELR results. The diseases 
in this study were campylobacteriosis, giardiasis, salmonellosis, and shigellosis. Both t-
tests, for public health response timeliness, and legal compliance timeliness were 
statistically different. However, it was determined that public health response time 
difference was not significant in later tests with a smaller confidence interval. 
There was no significant interaction between disease type and report type 
regarding public health response time. The result was significant regarding legal 
compliance time. This study showed that with both ELR and traditional reporting, it is 
impossible to prevent secondary infections when basing public health response on 
laboratory confirmation. The legal requirements time was inconclusive because the data 
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were provide in days, rather than minutes. In addition, the ANOVA for ELR and legal 
time suggested batched results when using ELR. This study showed that response 
timeliness is too long in Southern Nevada, with ELR and traditional reporting. More 
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Chapter 1 – Introduction 
This study compares the timeliness of traditional reporting and ELR at the 
Southern Nevada Health District (SNHD). Traditional reporting includes phone, fax, and 
paper reports. ELR is defined as the transmission of laboratory results sent from the 
testing laboratory to the public health authorities using electronic means (Centers for 
Disease Control and Prevention, [CDC] 2011a). 
 Faster reporting can lead to faster response by public health officials to prevent 
potential outbreaks and new cases, and to reduce the burden of infectious disease in the 
community. Nevada State law requires that diseases be reported in certain time frames. 
For many common diseases this timeframe is within 24 hours of a test result (Nevada 
Administrative Code [NAC] 441A, 2012). 
Electronic Laboratory Reporting (ELR) has been or is being implemented in 
many states and counties. ELR is faster and has fewer errors than traditional paper 
reporting (Nguyen, Thorpe, Makki & Mostashari, 2007).  In 2009, the Health Information 
Technology for Economic and Clinical Health (HITECH) Act, part of the American 
Recovery and Reinvestment Act (ARRA), became a law intended to expand the use of 
health information technology (HIT). Health care policy experts believe that HIT can 
improve quality, lower costs, and benefit the health of patients in multiple other ways. 
However, the use of HIT is considered to be low (Buntin, Burke, Hoaglin, & Blumenthal, 
2011).  The HITECH Act makes incentive payments to healthcare providers for 
implementing electronic medical records, as a part of the healthcare quality and efficacy 
goal of the Patient Protection and Affordable Care Act of 2010 (Buntin, et al. 2011).  In 
addition to accelerating HIT, the HITECH Act provides incentive payments to reimburse 
providers for meaningful use updates of electronic health systems (Lenert & Sundwall, 
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2012). Incentive payments are important because the implementation of electronic 
systems can be expensive, and there has been a lack of federal funding for health IT. 
Meaningful use regulations (part of HITECH) require electronic health record systems to 
include incentives for healthcare providers who are able to demonstrate the ability to send 
ELR data to health departments (Lenert & Sundwall, 2012). 
 The goal of this study is to assess the timeliness of laboratory reporting in 
Southern Nevada with regard to public health response, (i.e. is the time frame sufficient 
to implement appropriate public health investigations and responses to prevent and 
contain potential outbreaks?). The timeliness of laboratory reporting will also be assessed 
with regard to requirements set forth by Nevada state law.  The objective is to discover 
whether ELR is faster than traditional reporting. Timeliness will be examined from 1999, 
when the Office of Epidemiology (OOE) began collecting data in a standardized database 
through May 2012.  
Data from four infectious gastrointestinal (GI) illnesses were analyzed in this 
study, as GI infections are common in Southern Nevada; five of the top 10 illnesses 
reported to the OOE at SNHD are GI infections. National reporting timeliness of these 
illnesses on a case by case basis is not often very important or useful (unlike diseases 
such as anthrax); however it is very important locally. This information is necessary to 
contain and investigate outbreaks, which lowers the burden of disease in the community 
(B.J. Labus, personal communication, February 16, 2012).  The diseases in this study are 
campylobacteriosis, salmonellosis, shigellosis, and giardiasis. They are the four most 
common reportable GI infections in Southern Nevada for which data are collected on a 
case by case basis. Outbreaks of these diseases can be fast and spread easily to children, 
who can get sicker, or die more often than other populations (B.J. Labus, personal 
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communication, February 16, 2012). The type of disease was also examined with regard 
to timeliness of reporting.  
























Chapter 2 – Background and Significance 
Disease Reporting History and Policy 
 In the United States, infectious disease reporting legislation falls to the states. In 
some states, diseases are reported to local health departments. Some local health 
departments provide epidemiologic services. All US states and territories choose to 
participate in a national program though the Centers for Disease Control and Prevention 
(CDC) to report cases of diseases on the list of Nationally Notifiable Conditions (CDC, 
1990).  The list of Nationally Notifiable Conditions is based on the Council of State and 
Territorial Epidemiologist’s (CSTE) position statements, and voted upon yearly by state 
epidemiologists (CDC, 2012c). Reportable diseases are those that are required by state 
law to be reported to state or local health authorities. Notifiable diseases are diseases that 
are reported voluntarily to CDC by state or local health authorities (CDC, 2011b). 
Salmonellosis, shigellosis, and giardiasis are notifiable diseases. Campylobacteriosis is 
not nationally notifiable (CDC, 2011b). All of the diseases in this study are reportable in 
Nevada (NAC 441A, 2012). 
Although standardized reporting methods, such as the use of the Nationally 
Notifiable Conditions list are fairly recent, reporting of communicable diseases to 
authorities is not a new phenomenon. In 1741, in the colony of Rhode Island, tavern 
owners were required by law to report customers with contagious diseases to authorities 
(Smith, Hadler, Stanbury, Rolfs, & Hopkins, 2012). Voluntary disease reporting to health 
authorities began in Massachusetts in 1874 (CDC, 1990).  In 1878, the Public Health 
Service was commissioned by Congress to collect data on cholera, smallpox, plague, and 
yellow fever (Sickbert-Bennett, Weber, Poole, MacDonald, and Maillard, 2011). By 
1901, all US states had reporting systems in place to report some infectious conditions to 
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the local health authorities (CDC, 1990). By 1925, all US states were participating in 
national infectious disease reporting, partially due to the 1916 poliomyelitis epidemic and 
1918 influenza pandemic (CDC, 1990). 
 
History of Electronic Health Systems 
 Historically, health care has trailed behind other industries in adopting and 
implementing electronic systems and technologies (Classen and Bates, 2011). In 1968, a 
physician, Lawrence L. Weed published a paper in the New England Journal of Medicine 
discussing how computers need to be used for medical records because the current state 
of records was unorganized and not complete (Weed, 1968). He explained how he had 
implemented computer programs in his own practice, and that by having a database with 
many patients, later one could review it and revise it as needed for efficiency (Weed, 
1968). Weed has been called an “innovator” by Himmelstein and Woolhandler (2005), in 
their manuscript discussing history and Electronic Medical Record (EMR) systems. 
Himmelstein and Woolhandler (2005) also remark that Weed’s innovation, as well as 
other systems created in the 1960s and 1970s, are “optimistic,” but not practical with 
regard to cost. Hospital administrators believed that they had spent a lot of money on the 
electronic systems, but did not receive enough in return for them to keep the systems 
running. This was, in part, due to the systems being incomplete and creating problems 
such as medication errors (Himmelstein and Woolhandler, 2005). 
 Following in the footsteps of doctors such as Weed, a group of physicians and 
informatics scientists from Indianapolis, Indiana, hospitals and the Regenstrief Institute in 
Indianapolis began developing an electronic medical system in 1972. The goal of the 
Regenstrief Medical Record System (RMRS) developers was to simplify records by 
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eliminating paper and reducing paperwork, as well as making information more 
accessible to those who need it (McDonald et al. 1999). The Regenstrief Institute had 
success with their electronic programs, and is still working to develop improved reporting 
methods, and evaluating these methods (Overhage, Grannis, and McDonald, 2008). 
Another evaluation of the use of technology in laboratory reporting, McLure and 
Barnett (1994), made the case that paper and phone reports were inferior to facsimile 
(fax) machines and personal computers. They state that the technology would produce 
faster and more complete reports. One comment from McLure and Barnett’s 1994 paper 
notes a challenge that is still present: “true EDI [electronic data interchange] requires a 
standardized electronic format” (McLure and Barnett, 1994, Effler et al., 1999; Panackal 
et al., 2002; Zarcone et al. 2010). 
 
State and County Laws and Policy 
 Staes et al. (2009) explain that public health infectious disease reporting is 
mandated by law in each state in the United States, and is “the key step in a chain of 
events that results in public health actions.” Actions include investigation, immunization 
and chemoprophylaxis, treatment of infected contacts, control measures and 
identification of outbreaks. New cases of disease may occur when reports are delayed 
(Staes et al. 2009). Jajosky and Groseclose (2004) also examined disease reporting, 
and stated that a comparable review of disease reporting in multiple states was not 
possible, in part because states have different reporting laws and protocols. Jajosky and 
Groseclose (2004) also noted that the only disease analyzed in their review that had 
sufficient timeliness to contain a multistate outbreak was Hepatitis A, which has an 
incubation period of 30 days. Other diseases studied such as cryptosporidiosis (7 day 
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incubation period), Escherichia coli O157:H7 (4 day incubation period), salmonellosis 
(1.5 day incubation period), and shigellosis (3 day incubation period) did not have reports 
that were timely enough for appropriate public health response in the event of multistate 
outbreaks (Jajosky and Groseclose, 2004).  
 In 1998, North Carolina lawmakers amended the state’s administrative code so 
that laboratories would need to report diseases that physicians already reported in hopes 
that double reporting policies would improve completeness and timeliness of surveillance 
(Sickbert-Bennett, et al, 2011). The researchers found that timeliness, completeness and 
accuracy of reporting varied greatly by disease, but that after the implementation of the 
new surveillance program, completeness of reports did increase (Sickbert-Bennett, et al., 
2011). 
 
Traditional Laboratory Reporting 
 In 1984, chief epidemiologists in every state, Puerto Rico and Washington, DC 
answered a survey that showed that 54% of jurisdictions required laboratory reporting of 
notifiable diseases (Sacks, 1985). For notifiable and reportable diseases to meet case 
definitions as “confirmed cases,” laboratory confirmation is often required (CDC, 2012c). 
States are free to set their own laws regarding infectious disease reporting, as noted 
earlier (CDC, 1990), and Nevada requires laboratories to report reportable and notifiable 
diseases to health authorities (NAC 441A, 2012). 
Another paper aiming to evaluate laboratory reporting assessed the National 
Notifiable Diseases Surveillance System (NNDSS), a non-electronic system maintained 
by the CDC. U.S. states territories report nationally notifiable diseases to the NNDSS. 
This system was examined in a paper reviewing studies of reporting timeliness (Jajosky 
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and Groseclose, 2004). Eight papers were assessed in Jajosky and Groseclose’s (2004) 
manuscript; three analyzed national reporting time, and five assessed local or state 
reporting timelines. Seven diseases were selected by Jajosky and Groseclose (2004) for 
analysis. They used laboratory confirmation as selection criteria for the diseases. The 
papers varied too much to produce comparable results, and it was suggested that other 
studies should describe the processes that contribute to the timeliness measured, and a 
description of the reporting process so that other papers can be compared. One of the 
limitations noted in this review was that different states have different protocols which 
could account for some variation in timeliness (Jajosky and Groseclose, 2004).  
 The U.S. is not the only country evaluating laboratory reporting timeliness. 
Research from the Netherlands examined timeliness by phone, fax, e-mail or post.  
Reporting rates were based on incubation period (corrected to account for latent 
infectious time for two diseases), and varied from 0.4%-78.7% (after correction) of 
diseases being reported within one incubation period, with this being important for 
prevention of secondary infections. ELR is not used in the Netherlands; however, the 
authors suggest that it should be to improve the “disappointingly large” number of 
unreported infectious disease cases (Reijn, Swaan, Kretzschmar, and Steenbergen, 2011). 
 
Electronic Laboratory Reporting 
 In 2006, the New York City Board of Health legally mandated ELR for notifiable 
diseases. The New York City Department of Health and Mental Hygiene (NYC 
DOHMH) ELR system was evaluated by interviewing informatics and surveillance 
employees about the benefits and barriers to the implementation of the system. Data 
examined showed that ELR was generally faster than paper (median of 6 days from 
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specimen collection to report compared to 25 days with paper), but testing that was 
complex or needed multiple tests was not faster using ELR. (Nguyen et al. 2007). For 
example, tuberculosis tests are conducted and reported on multiple specimens, Nguyen et 
al. (2007)  also reported that because syphilis is not added to a registry until after past 
tests have been reviewed, ELR was not timelier (Nguyen et al. 2007).   
 In a similar study, research conducted at the Florida Department of Health 
(FDOH) showed that the full implementation of ELR could improve timeliness (Kite-
Powell, Hamilton, Hopkins, DePasquale, 2008).  Rather than evaluate the implementation 
of an electronic system, the authors assumed ELR would save time and calculated 
potential improvement for four diseases. The diseases varied in increased timeliness, with 
no change for meningococcal disease, 3 days faster for hepatitis A (from 13 to 10 days), 4 
days faster for shigellosis (from 10 to 6 days), and 5 days faster for salmonellosis (from 
12 to 7 days) (Kite-Powell et al. 2008).  
 
Automated ELR 
 An evaluation of automated ELR shows faster report time (Overhage, et al. 2008; 
Panackal et al. 2002; Effler et al. 1999). Automated ELR means that there is not a person 
who manually sends all of the reports from the laboratory to the health department, 
rather, the system is set to code results in a standardized format, and the computers 
connect automatically. The Hawaii Department of Health used a prototypical automated 
ELR system and found that ELR was and average of 3.8 days faster than traditional 
reporting (Effler et al. 1999). Research in Allegheny County, Pennsylvania showed that 




Also evaluating automated ELR, researchers from the Regenstrief Institute 
assessed timeliness in Marion County, Indiana. They found that automated ELR was 7.9 
days faster than traditional reporting (Overhage et al. 2008). The investigators also 
evaluated the cost after ELR implementation, and reported that after the software was 
developed, there were very low maintenance costs, in part due to the standardized data 
format of the system. They also reported that “the improved completeness and timeliness 
of ELR reporting also lead to benefits in that the public health interventions can be 
initiated at an earlier point, leading in turn to fewer lost workdays, fewer direct medical 
costs, decreased probabilities that antimicrobial resistance will develop, and decreased 
mortality” (Overhage et al. 2008). 
 
Infectious Diseases and Testing Methods 
 Research shows that testing methods have influence over timeliness of disease 
reporting (Nguyen et al. 2007; Staes et al. 2009).  Multiple tuberculosis tests, as stated 
above, made ELR difficult for the NYC DOHMH; as did the review of past tests for 
syphilis. When multiple tests are required for a result confirmation, the time it takes to 
conduct and process the results from each test factors into timeliness (Nguyen et al. 
2007). Staes et al. (2009) found in a survey that 82% of urgent care providers in clinics in 
Utah and Idaho ordered the recommended test for pertussis, which is a polymerase chain 
reaction (PCR). The remaining 18% ordered a test that would increase reporting time 
possibly by weeks (culture) or tests with low sensitivity and (direct fluorescent antibody 
[DFA]) (CDC, 2006). Essentially the study by Staes et al. (2009) showed that when 
providers used the wrong tests, report times could increase due to the time for the test to 
produce a result. In addition, using a faster test that does not work as well can cause false 
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positives or negatives, which can lead to incorrect prevalence rates of the disease in 
question (Staes et al. 2009). 
 In another paper examining infectious disease laboratory reporting, investigators 
found that in North Carolina that diseases with laboratory-based case definitions (such as 
salmonellosis) were more likely to be reported at all, as were diseases with few criteria 
because laboratory reporting is more straightforward than clinician reporting (Sickbert-
Bennett, et al. 2011).   
Salmonellosis is the most common reportable GI illness in Southern Nevada (B.J. 
Labus, personal communication, February 16, 2012). The infection is caused by 
Salmonella spp. bacteria which are ingested. Campylobacteriosis is a zoonotic bacterial 
infection caused by the organism Campylobacter jejuni. Shigellosis is caused by Shigella 
spp. bacteria, and can cause dysentery (Heymann, 2008). Giardiasis is a protozoal illness. 
Giardia cysts are difficult to kill with chlorine, so outbreaks of giardiasis often result 
from contaminated water. All of these illnesses cause diarrhea, vomiting, and other 
gastrointestinal symptoms (Heymann, 2008).  Although all four of these diseases are 
reportable in Nevada (NAC.441A, 2012), campylobacteriosis is not a nationally 
notifiable disease. Campylobacteriosis does have a standard case definition (CDC, 2012c) 
(See Appendix 3 for case definitions). 
Salmonellosis and shigellosis are tested using culture, as is campylobacteriosis 
(Mims, Playfair, Riott, Wakelin, Williams, 1998; CDC, 2010), and giardiasis is 
confirmed by an ova and parasite (O&P) exam or immunoassay (CDC, 2012a). 
A study of the use and timelines of clinical disease testing in laboratories in 
Georgia found that a giardiasis test (for one of three required O&P tests) could be 
completed in 1 day when performed in-house rather than sent to a commercial laboratory 
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(Brzozowski, Silk, Berkelman, Loveys, & Caliendo, 2012). Brzozowski, et al. (2012)  
also evaluated other diseases with regard to timeliness and found that in general, when 
specimens were sent to commercial laboratories rather than tested at hospitals or clinics, 
report time increased. Increased report time can cause the prevalence of diseases to 
appear lower than they are, and prevent appropriate measures from being implemented in 
the case of a potential outbreak (Brzozowski, 2012). 
In this study, public health response time is defined as the timeframe from onset 
of symptoms to the report being received at SNHD. Legal compliance time is defined as 





Numerous studies of public health response timeliness use the onset of symptoms 
to report to the health authorities to evaluate this timeframe. This timeframe is important 
because it can provide public health authorities with information about epidemiologic 
contacts of those who test positive. The information can be used to help prevent or 
control outbreaks of disease, or to find the source of infection (Jajosky and Groseclose, 











Incubation period of disease
Legal compliance time
(24h)
Figure 1. Disease Reporting Timeline 
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This timeframe can be subjective because it is often reported by patients to clinicians. 
Although, all of the diseases in this study have GI symptoms, giardiasis can be 
asymptomatic in some patients (Heymann, 2008). 
The legal compliance timeframe is examined to determine whether or not ELR is 
faster than traditional laboratory reporting. The four diseases in this study are required to 





















Chapter 3 – Methods 
Study Design 
This study is a retrospective secondary analysis of extant data. The data were 
collected as part of legally mandated public health practice. These data have not been 
evaluated comparing the timeliness of ELR to traditional laboratory reporting in this way 
prior to this study. 
 
Research Questions & Hypotheses 
1. How does traditional reporting compare with ELR with regard to public health 
response timeliness (i.e. is the time frame sufficient to implement an appropriate public 
health investigation and response to prevent and contain potential outbreaks based on 
incubation period of diseases)? 
 
Ho: There is no difference in report time. 
 
Ha: There is a difference in report time with the prediction that ELR will be faster than 
traditional reporting. It is unknown whether the timeframe for each method will provide 
sufficient time for an appropriate investigation and response, if needed. It is predicted 
that timeframe will be sufficient with ELR. These predictions are based on literature that 
shows that the use of ELR speeds up report time. 
 
2. How does traditional reporting compare with ELR with regard to timeliness reporting 




Ho: There is no difference in report time. 
 
Ha: There is a difference in report time with the prediction that ELR will be faster than 
traditional reporting. This prediction is based on literature showing that the use of ELR 
speeds up report time. 
 
3. What is the impact of disease type when traditional reporting is compared to ELR with 
regard to public health response timeliness and legal timeliness requirements? 
 
Ho: There is no difference in report time. 
 
Ha: There is a difference in report time. The prediction is that ELR will be faster than 
traditional reporting; however giardiasis will have the longest timeframe. This prediction 
is based on literature showing that the microbiology of laboratory testing methods of 
specific diseases can affect the timeliness of reports.  
 
Variables 
Predictor (X1): Report type (dichotomous: Traditional [1999-May 2004] ELR [July 2004-
May 2012]) 
 
Predictor (X2): Disease type (Categorical [4 categories]: Salmonellosis, 
campylobacteriosis, giardiasis, shigellosis) 
 
Outcome (Y1): Response time in days (continuous) 
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Outcome (Y2): Legal time in days (continuous)  
 
 The predictor variables are both categorical variables. The first one is 
dichotomous (ELR or traditional laboratory reporting) which means that is has low 
statistical power. However, the two outcome variables are both continuous, but discrete 
as the data were provided in days. Continuous data are statistically more powerful 
(Hulley, Cummings, Browner, Grady, & Newman, 2007). Independent samples t-tests 
can be used with these variables.  
 The second predictor variable (disease type) is categorical, with four categories, 
or four diseases. To determine interaction effects, two-way analysis of variance 
(ANOVA) tests can be used (Pallant, 2007). 
 
Data Acquisition and Ethical Concerns 
 The data used for this study were collected as part of legally mandated public 
health surveillance activities (NAC.441A, 2012) by the Office of Epidemiology at the 
Southern Nevada Health District (SNHD), as authorized by Nevada Revised Statute 
[NRS] 439. 
The data were de-identified to comply with NRS 441A.220 (2011). No patient 
identifiers were used. The data set includes disease name and year of occurrence (See 
Appendix 1: Data Dictionary). Dates were removed and the number of days between 
onset date, test result, and report date, were calculated to conduct an appropriate 
statistical analysis.  
The reports come from two large commercial laboratories in Southern Nevada 
that provide approximately 90% of SNHD’s reports (B.J. Labus, personal 
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communication, February 16, 2012). Data from the two labs only is used because 
secondary infections identified by a diseases investigator could potentially be reported in 
a more timely manner than reports from a laboratory, and this is an evaluation of 
laboratory timeliness not investigator speed. In addition, smaller laboratories do not yet 
have ELR data to compare with traditional reports (B.J. Labus, personal communication, 
February 16, 2012). 
The University of Nevada, Las Vegas Institutional Review Board approved an 
exemption for this study in July 2012 (Protocol #1205-4153). 
 
Inclusion and Exclusion of Data 
 Timeliness will be examined using four common diseases in Southern Nevada 
from 1999 when the OOE began a morbidity database through May 2012. The diseases 
chosen for this study are salmonellosis, campylobacteriosis, giardiasis, and shigellosis. 
Figure 2 shows the ten most common diseases reported to the SNHD from 1999 to 2012. 
These diseases include respiratory syncytial virus (RSV), rotavirus, novel A influenza, 
salmonellosis, campylobacteriosis, giardiasis, shigellosis, aseptic meningitis, and 
coccidioidomycosis (Valley Fever). RSV and novel A influenza were excluded from this 
study because the data is aggregated weekly – there are no case-level data. Rotavirus was 
excluded because the SNHD database was missing four years of case-level rotavirus data 
(B.J. Labus, personal communication, February 16, 2012).  Aseptic meningitis and 
coccidioidomycosis were excluded because neither of those two diseases requires a 
public health response from SNHD. This left salmonellosis, campylobacteriosis, 
giardiasis, and shigellosis in the data set (Figure 2). 
 The Office of Epidemiology provides investigation protocols to employees via 
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SNHD intranet. The following paragraphs are summaries of these protocols. Currently, 
the routine investigations (not outbreak-related) for campylobacteriosis and giardiasis are 
limited to children who are three years of age or younger. Prior to June 8, 2009, all 
campylobacteriosis and giardiasis cases were investigated. All salmonellosis and 
shigellosis cases are investigated (B.J. Labus, personal communication, October 15, 
2012). 
 The response for campylobacteriosis includes notification of the patient’s health 
care provider. If the patient is ≤3 years old, the report is from an outbreak, or the patient 
works in sensitive occupation, such as food handler or child care provider, an 
investigation is initiated, and information regarding the onset date, symptoms, test results, 
medications, and parental occupation if the patient is a child. Education is provided to the 
patient or parents about disease transmission, personal hygiene, and food safety. Children 
who are positive for campylobacteriosis cannot attend child care, and workers in sensitive 
occupations may not attend work until symptoms are gone (B.J. Labus, personal 
communication, October 15, 2012). 
 The response for giardiasis is similar to the response for campylobacteriosis. In 
addition to the information noted above collected for patients three years of age or 
younger, parents of giardiasis cases are also questioned about travel and exposure to child 
care facilities, other people with GI illness, pets, and water (drinking and recreational). 
Children and contacts of children with giardiasis cannot go to child care facilities until 
treatment (anti-parasitic medication) has been provided and diarrhea has stopped. 
Giardiasis cases in a daycare setting are treated as potential outbreaks to identify whether 
other children or staff members could have giardiasis (B.J. Labus, personal 
communication, October 15, 2012). 
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 Salmonellosis cases are all investigated. If the case is part of an outbreak, 
demographic, epidemiologic and laboratory information are collected. If the case is not 
related to an outbreak, disease investigators look for matching laboratory results (from 
other patients), to identify possible clusters or outbreaks. Patients are contacted and 
educated regarding transmission of the disease, personal hygiene, carrier state possibility, 
and food safety. Carriers of salmonellosis are uncommon, but 1% of adults and 5% of 
children under age five can carry the disease asymptomatically for a year or more (B.J. 
Labus, personal communication, October 15, 2012). 
 The infectious dose of shigellosis is very small, so it is very contagious 
(Heymann, 2008).  All shigellosis cases are investigated in Clark County. Demographic 
information is collected from the health care provider, as well as information regarding 
the disease. Laboratory results are examined to determine appropriate antibiotic 
treatment. Cases are contacted and provided with information regarding transmission, the 
small infectious dose, hygiene, food safety, refraining from oral and anal sex until the 
bacteria is no longer detected, and disposing of diapers (B.J. Labus, personal 
communication, October 15, 2012). 
 Control measures for salmonellosis and shigellosis include contacting school 
nurses, child care management, or food establishment management regarding other 
possible cases and determining when children or workers can come back. The 
Environmental Health department at SNHD will be notified if infections started at child 
care facilities or schools (B.J. Labus, personal communication, October 15, 2012). 
 The period of communicability for the four diseases in this study generally begins 
at the onset of symptoms, (Heymann, 2008) which means that there will be no need for 
extra calculations to account for infectious time before symptoms begin.  
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The OOE does not collect sexually transmitted infection, HIV/AIDS or 
tuberculosis reports, so those diseases were not considered. Further exclusion includes 
cases with blank cells, negative numbers of days, and with days above 30 because these 
four diseases have incubation periods that are generally less than two weeks (often only a 
few days) (Heymann, 2008). Also excluded were cases in June of 2004 during the time 
that ELR systems were implemented (B.J. Labus, personal communication, February 16, 
2012). This was done to avoid errors from laboratory workers learning a new system. 
Incubation period was used as a proxy of period of communicability, as that is common 
















































































































































































































































































































































































































































































































































Figure 2. Inclusion and Exclusion Criteria for Diseases 
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Statistical analysis:  
 The first predictor variable (report type) is a dichotomous variable. The 
year variable was recoded from year and month to 0 = Traditional reporting, and 1 = 
ELR. The second predictor variable (disease) is a categorical variable with 4 categories. 
The disease name variable was recoded from disease name to 1 = campylobacteriosis, 2 = 
giardiasis, 3 = salmonellosis, 4 = shigellosis. The outcome variables (time in days) are 
continuous (See data dictionary, Appendix 1). 
Kolmogorov-Smirnov tests for normality were conducted.  Independent samples 
t-tests were used to test first two hypotheses. The Levene’s test for equal variance 
(conducted automatically in an independent samples t-test) was also conducted. The level 
of significance was set at p < 0.05. 
Two-way analyses of variance (ANOVA) were used to test interaction effects for 
the third hypothesis, one for public health response time and one for legal compliance 
time. Levene’s tests for equal variances were also conducted. In a two-way ANOVA, if 
the variance is unequal, a more stringent level of significance needs to be set to account 
for error (Pallant, 2007). The level of significance was set at p < 0.01. A Tukey’s 
Honestly Significant Difference (HSD) post-hoc test is the standard test to further explore 
a two-way ANOVA. Tukey’s HSD post hoc tests were conducted. To further explore 
significant interaction effects, the data set must be split by one of the interaction 
categories and one-way ANOVAs with Tukey’s post hoc tests are run for each of two 
categories. These tests were also conducted. 
Microsoft® Excel, 2010 and IBM® SPSS® Statistics software, version 20 were 




Chapter 4 – Results 
Data Characteristics 
 A total of 2,425 laboratory results were used to conduct this study. The first result 
was from December of 1998, when the OOE began the morbidity database. The final 
result was from May 2012. The data consisted of 1,082 traditional reports (44.6%) and 
1,343 ELR results (55.4%) (Table 1). 
Table 1. Frequency of Electronic and Traditional Reports 
 Frequency Percent 
Traditional Reports 1,082 44.6 
ELR 1,343 55.4 
Total 2,425 100.0 
 
The four diseases in this study were campylobacteriosis (n = 716), giardiasis (n = 
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Kolmogorov-Smirnov tests for normality were conducted to determine whether to 
use parametric or nonparametric statistical tests, and the data were not normally 
distributed (p <0.001, violating the assumption of normality). Histograms showed slightly 
negatively skewed data for public health response time reports, and positive kurtosis for 
legal time reports and negative skew. In general, the distribution appeared fairly normal 
(Figures 5 and 6). Due to the samples sizes containing more than 200 cases, the skew and 












Public Health Response Timeliness 
 With regard to public health response, an independent samples t-test showed a 
significant difference in the timeliness in days between ELR (M = 10.84d, SD = 5.501) 
and traditional reporting (M = 10.35d, SD = 6.427); t = -1.991, p = 0.047 (two-tailed).  
The effect size of the differences in the means (mean difference = -0.419, 95% CI: 
-0.974 to -0.007) was very small (eta squared = 0.002). The eta squared means that only 
0.2% of the variance in dependent variable can be explained by the test type (ELR or 
traditional reporting) (Table 2 and Table 3). Levene’s test for equality of variances 
showed unequal variance (F = 23.933, p > 0.001). 
 
Figure 6. Distribution of Legal Time Data with Normal Curves 
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Table 2. Public Health Response Timeliness Data Characteristics 
 N Mean (days) Standard Deviation 
ELR 1,343 10.84 5.501 
Traditional Reports 1,082 10.35 6.427 
 
 
Table 3. Public Health Response Timeliness T-test for Equality of Means 
T Degrees of freedom 
p Mean difference 95% Confidence 
Interval 
Eta squared 
-1.991 2134.594 0.047 -0.491 -0.974 to -0.007 0.002 
  
Timeliness of Legal Compliance 
 With regard to legal time, an independent samples t-test revealed a significant 
difference in time in days between ELR (M = 5.23d, SD = 2.706) and traditional 
reporting (M = 4.02d, SD = 2.173); t = -12.223, p > 0.001 (two-tailed). The effect size of 
the differences in the means (mean difference = -1.212, 95% CI: -1.407 to -1.018) was 
moderate (eta squared = 0.058) (Table 4 and Table 5). Levene’s test for equality of 
variances showed unequal variances (F = 8.836, p = 0.003). ELR was slower than 
traditional reporting. 
 
Table 4. Legal Timeliness Data Characteristics 
 N Mean (days) Standard Deviation 
ELR 1,343 5.23 2.709 
Traditional Reports 1,080 4.02 2.173 
 
 
Table 5. Legal Response Timeliness T-Test for Equality of Means 
T Degrees of freedom 
p Mean difference 95% Confidence 
Interval 
Eta squared 
-12.223 2420.987 0.000 -1.212 -1.407 to -1.018 0.058 
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REPORT TYPE AND DISEASE TYPE INTERACTIONS   
Public Health Response Stratified by Disease 
First, mean days of report type (ELR and traditional reporting) were stratified by 
disease with regard to public health response time using a two-way ANOVA. 
Campylobacteriosis, salmonellosis, and shigellosis were more timely with traditional 
reporting, however giardiasis was faster with ELR (Figure 7).   
A Levene’s test of equality of variances showed that the variance was unequal (p 
< 0.001), therefore significance was set at p < 0.01 to account for error (Pallant, 2007). A 
two-way ANOVA showed that disease type did not influence report type with regard to 
public health response. The interaction effect was not statistically significant (F = 2.087, 
p = 0.10).  
There was a statistically significant difference between disease types (F = 9.402, p 
< 0.001). A Tukey’s HSD post hoc test revealed that timeliness of giardiasis reports  
(M = 11.71d, SD = 8.440) was significantly different from campylobacteriosis reports 
 (M = 10.23d, SD = 5.021), salmonellosis reports (M = 10.40d, SD = 4.853), and 
shigellosis reports (M = 10.03d, SD = 4.269).  
The ANOVA also revealed that with a more stringent alpha (p <0.01), timeliness 
of test type was not significantly different between ELR and traditional reporting (F = 
4.591,  
p = 0.023). The effect size was very small (partial eta squared = 0.002) (Table 6). 
Table 6. Two-Way ANOVA Results – Public Health Response Timeliness 
 F p* Partial eta squared 
Disease type 4.591 0.000 0.012 
Report type 4.591 0.023 0.002 
 
Disease type*Report 
Type 2.087 0.100 0.003 






Legal Compliance Timeliness Stratified by Disease 
Mean days for report type were then stratified by disease with regard to legal 
compliance time. All diseases were more timely with traditional reporting, however 
shigellosis was approximately the same (M = 5.52d for traditional reporting compared to 
a mean of 5.53d for ELR) (Figure 8).   
A Levene’s test of equality of variances showed that the variance was unequal for 
these data as well (p < 0.001).  Significance was set at p < 0.01 (Pallant, 2007). A two-
way ANOVA revealed a significant interaction between report type and disease type, 
suggesting that one could influence the other (F = 22.257, p < 0.001). Also significant 
were differences in timeliness between disease types (F = 140.127, p < 0.001) and 
between report types, as expected (F = 60.849, p < 0.001). The effect sizes were also 
higher with the legal compliance time than public health time, showing that more of the 
Figure 7. Public Health Response Time – Mean Days by Disease Type and Report Type 
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variance in timeliness can be explained by report type or disease type  (Table 7).  
A Tukey’s HSD post hoc test showed that all diseases differed significantly in 
average response days except campylobacteriosis (M = 4.94d, SD = 2.407) and 
shigellosis (M = 5.53d, SD = 2.211) (giardiasis M = 2.86d, SD = 2.610; salmonellosis M 
= 5.46d,  SD = 2.084). 
 
Table 7. Two-Way ANOVA Results – Legal Compliance Timeliness 
 F p* Partial eta squared 
Disease type 140.127 0.000 0.148 
Report type 60.849 0.000 0.025 
Disease type*Report 
Type 22.257 0.000 0.027 





One-way ANOVAs were run (Pallant, 2007) with Tukey’s HSD post hoc tests for 
Figure 8. Legal time – Mean days by disease type and report type 
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using traditional report type, showed that all diseases except salmonellosis (M = 5.24d, 
SD = 1.696) and shigellosis (M = 5.52d, SD = 2.176) differed significantly from each 
other in average response days (Traditional reports of campylobacteriosis M = 4.53d, SD 
= 1.674; giardiasis M = 1.96d, SD = 1.349) (Table 8). 
The ELR test showed only giardiasis (M = 4.15d, SD = 3.340) differing in time 
from other diseases (campylobacteriosis M = 5.25d, SD = 2.812; salmonellosis M = 
5.62d, SD = 2.298; shigellosis M = 5.53d, SD = 2.231).  
 
Table 8. One-way ANOVA results – Legal Compliance time ELR compared with 
Traditional Reporting 
 F p* 
Traditional Reporting 278.979 0.000 
ELR 17.683 0.000 















Chapter 5 – Discussion 
The aim of this study was to evaluate the difference between traditional laboratory 
reporting and ELR timeliness among two major laboratories that do infectious diseases 
testing for SNHD from 1999-2012.  The findings suggest that for the four GI illnesses in 
this study (campylobacteriosis, giardiasis, salmonellosis, and shigellosis), traditional 
reporting is faster than electronic reporting. 
The data were not normally distributed. The violation of normal distribution is 
common in large samples, such as the sample in this study (N = 2,425). The data were 
not adjusted due to the samples sizes containing more than 200 cases. The skew and 
kurtosis should not affect the results in a significant way (Pallant, 2007).  
The first hypothesis, that report times between ELR and traditional reports will 
differ with regard to public health response time, was supported by the initial t-test 
performed. However, when further analysis was done, with a more stringent level of 
significance, the difference between ELR and traditional reporting failed to be 
statistically significant. The confidence interval was changed from 95% to 99% in the 
two-way ANOVA because there is no two-way ANOVA post hoc test to correct for 
unequal variance in the data. The way to correct for error is to change the level of 
significance to p < 0.01 (Pallant, 2007). The null hypothesis cannot be rejected. With 
regard to public health response (defined as the time in days between the onset of illness 
and the test result reported to SNHD), it was predicted that ELR would be faster than 
traditional laboratory reporting. The results showed the opposite – the mean number of 
days for ELR was 10.84 (SD = 5.501), and 10.35 (SD = 6.472) for traditional reporting. 
This was a significant difference when p < 0.05, but not when p < 0.01. The effect size 
measured with t-tests and ANOVA was 0.002, which is very small. That means that 0.2% 
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of the variance in the dependent variable (time) can be explained by the independent 
variable (ELR or traditional laboratory reporting) (Pallant, 2007).  
In addition to determining if ELR is faster than traditional reporting, the objective 
of the public health response research question was to determine whether or not the time 
frame was sufficient to implement appropriate public health investigations and responses 
to prevent and contain possible outbreaks. The average number of days for all four 
illnesses in both report categories is above 10 days, which suggests that neither method is 
sufficient to implement public health responses. It could be impossible to prevent 
secondary infections of salmonellosis and shigellosis, which both generally have 
incubation periods of 1-3 days (Heymann, 2008).  Although giardiasis testing can be 
completed in the mandated 24-hour timeframe, confirmation can require three specimens 
24 hours apart (Heymann, 2008). 
 The second hypothesis, which states that report times will differ between ELR 
and traditional reporting with regard to timeliness requirements set forth by state law, was 
supported by the t-test performed, as well as the ANOVA. This time frame is defined as 
the amount of time in days between the test result in the laboratory and the report to 
SNHD. State laws NAC.441A (2012), require campylobacteriosis, giardiasis, 
salmonellosis, and shigellosis results to be reported within 24 hours of obtaining the 
result.  
The laboratories evaluated in this study use a culture to test salmonellosis, 
campylobacteriosis, and shigellosis, which can take up to 72 hours to produce a result. 
The laboratories have 24 hours to report the result after the culture has produced a result. 
This can be up to 96 hours combined. Giardiasis is tested using an ova and parasite exam 
or antigen test (which can be completed in 24 hours) (B.J. Labus, personal 
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communication, February 16, 2012). However, confirmation of giardiasis by O&P 
requires three separate specimens 24 hours apart (Heymann, 2008).  
The results of the t-test for this hypothesis show that the difference in time 
between ELR and traditional reporting was statistically significant. However, the 
prediction that ELR would be faster than traditional reporting was incorrect. The average 
number of days to report a result using traditional reporting was 4.02 days (SD = 2.173), 
with ELR, 5.23 days (SD = 2.709). These results are very close to the time frame set forth 
by state law. This research question is limited by the data, specifically a time frame 
reported in days. An ideal measure for this hypothesis would have been time in hours.  
 The third hypothesis, whether the disease type would make a difference in time 
between ELR and traditional reporting was supported by the results with regard to legal 
response time. Stratification by disease was tested because the testing methods for these 
diseases likely influence the timeliness. However, there was no interaction between 
public health response time and report type.  
Post hoc test revealed that timeliness of giardiasis reports (M = 11.71d, SD = 
8.440) was significantly different from campylobacteriosis reports (M = 10.23d, SD = 
5.021), salmonellosis reports (M = 10.40d, SD = 4.853), and shigellosis reports (M = 
10.03d, SD = 4.269). These results agreed with the prediction that giardiasis reporting did 
take longer than the other diseases, for public health response time. Campylobacteriosis, 
salmonellosis, and shigellosis were more timely with traditional reporting, as seen in the 
t-test, however giardiasis was slightly (though not significantly) faster with ELR – this 
was a new result (M = 11.75d [SD = 8.760] for traditional reporting, and a mean of 
11.65d [SD = 7.980] for ELR). 
When legal compliance timeliness was examined, a two-way ANOVA revealed a 
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significant interaction between report type and disease type, suggesting that disease type 
could influence the timeliness of ELR or traditional reporting. Due to the significant 
interaction effect, the data were split by ELR cases and traditionally reported cases, and 
one-way ANOVAs were performed on each report type separately, as this is the way to 
further test interactions (Pallant, 2007).  
The ANOVA results for both types of reporting were significant. With traditional 
reporting, there were significant differences between the report times in days of all 
diseases except between salmonellosis (M = 5.24d, SD = 1.696) and shigellosis (M = 
5.52d, SD = 2.176). However, when the ANOVA was run on the ELR data, the results 
showed that giardiasis was the only disease with report times (M = 4.15d, SD = 3.340) 
that differed significantly than the other three (campylobacteriosis M = 5.25d, SD = 
2.812; salmonellosis M = 5.62d, SD = 2.298; shigellosis M = 5.53d, SD = 2.231).  
This result could suggest that using ELR is resulting in more batched results from 
laboratories to health authorities  (for example, tests are all sent by computer one time in 
a day, rather than paper reports or phone calls that could happen multiple times in a day). 
Batching occurs because although all results go into a computer, the results may only be 
sent to the health authorities one time each day, when someone pushes a send button.  
This is common in ELR systems that are not fully automated with real time reporting 
from laboratories to health authorities (B.J. Labus, personal communication, September 
28, 2012). Although it does not seem practical that a laboratory worker would make a 
telephone call every time a result is found, telephone calls are not as batched as electronic 
reports. 
As noted earlier, the traditional reporting data (M = 4.02d, SD = 2.173) for legal 
compliance time was significantly faster than the ELR (M = 5.23d, SD = 2.706). This is 
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also something that could be due to batching of results. An example of why this could 
happen is if the lab worker has already sent the results for the day to the health authorities 
at 4:58 pm, a new result shows up at 4:59 pm, and he is off work at 5:00 pm, it would not 
be uncommon for him to group this result with the next day’s data, especially in cases of 
diseases that require 24 hour notice, not immediate notice. If the system was fully 
automated with real time ELR, the result could be immediately sent to the health 
authorities. To get fully accurate data for timeliness in cases such as these, the data would 
have to be analyzed in minutes, as it only takes people minutes to enter data.  
Literature examining automated ELR systems shows that real time reports are 
more complete and faster. Overhage et al. (2008) discovered that the real time ELR 
system they used was on average eight days faster than paper reporting. Overhage et al. 
(2008) also examined other systems in the US, such as the ELR used in Hawaii. They 
determined that the Hawaii system, which used batched file transfer, failed with about 
one third of records (either the results were not received or the results were incorrect or 
incomplete) (Overhage, et al. 2008). Researchers in Allegheny County, PA found that by 
using real time ELR, there were fewer errors and duplicate reports. This was due to the 
use of a standardized set of results and faster reporting in general (Panackal et al. 2002).  
The results of this study disagree with literature that says ELR is faster than 
traditional reporting (Kite-Powell et al. 2008; Nguyen et al. 2007). However, if the 
laboratories in the study were to implement fully automated, real time ELR systems, the 
results might be in agreement with more of the literature.  
As noted in literature above, ELR is faster, has more complete information, and 
sometimes more accurate information (Kite-Powell et al. 2008; Nguyen et al. 2007; 
Sickbert-Bennett et al. 2011). Many studies evaluating automated ELR have found faster 
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report times. (Overhage et al. 2008; Effler et al. 1999; Panackal et al. 2002). The research 
team at the Regenstrief Institute found that ELR was 7.9 days faster than traditional 
laboratory reporting. They also determined that the maintenance cost after 
implementation was very low (Overhage et al. 2008).  
Effler et al. (1999) state that they believe ELR will improve disease reporting 
quality with more complete and timely reporting. They also believe that ELR will be 
more cost effective than traditional laboratory reporting because it will reduce time that it 
takes for people to fill out paper forms (Effler et al, 1999).  
Another benefit of using ELR found by Panackal et al. (2002) was less human 
error. In evaluating their ELR system, they determined that error in completeness and 
accuracy of reports was almost always caused when people were able to type free text, 
rather than using standardized disease codes. In addition, almost all false positives were 
caused by the use of free text, instead of standardized result codes (Panackal et al. 2002). 
 
Limitations 
There are several limitations to consider when discussing the results of this study. 
First, these data were not collected for research purposes. These data were collected as a 
part of legally mandated public health surveillance (NAC.441A, 2012). The research 
questions and hypothesis were not conceived until after the data collection, therefore, this 
is a secondary analysis.  
In addition, only four diseases were studied, and while selected for convenience 
(short incubation time, obvious symptoms, and high number of reports), may not be 
representative of all diseases tested by the laboratories in the study. External validity may 
be limited with this study as Southern Nevada is unique. There are high volumes of 
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travelers, and this study does analyze diseases with short incubation periods (Las Vegas 
Convention and Visitors Authority, 2011).  
Data from two commercial laboratories were analyzed in this study. Reports from 
one of the laboratories account for approximately 70% of laboratory results received by 
SNHD. The other laboratory accounts for approximately 20% of the results received at 
SNHD (B.J. Labus, personal communication, February 16, 2012). If the laboratory 
sending most of the reports is the slower one, that could add bias to the study. 
Another limitation specific to the public health response hypothesis is that onset 
date of symptoms is often self-reported  by patients. Although the beginning of a GI 
illness should be fairly easy to determine, self-reported data could have recall bias.  
 Finally, the timeframe of the report times was provided in days. If batching is 
occurring using electronic systems, it is not possible to know it from this study. Time 
would need to be provided in hours or minutes to get a more accurate picture of why the 
disease type does interact with report type. 
 
Recommendations 
In 2010, a new surveillance system was implemented at SNHD, which included 
more automation of electronic systems (B.J. Labus, personal communication, February 
16, 2012), so it is possible that the timeliness of ELR will increase as more technology is 
implemented. In addition, the system could send results in real time, rather in batches.  
 The human component also cannot be completely ignored with ELR, because the 
systems in place now are not fully automated; laboratory employees must still enter in 
results and send in reports. If a human types in the wrong code or an extra number 
somewhere, it can change the results completely. It could be very hard to measure human 
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error, but it is expected that this will be an issue with slow times using electronic systems, 
especially immediately after implementation. One way to evaluate human error is to look 
for consistencies in the errors (fixed error), for instance the same wrong codes typed in 
every time by a certain person. If this is the case, it would be useful to determine so that 
educational interventions could take place if needed.  Future studies could examine the 
fixed error, if any, among laboratory results. 
 Effler et al. (2002) found that most human error was caused by free text, and that 
standardized code sets eliminated a great deal of this error. It would be beneficial to 
laboratories in Southern Nevada to implement standardized code sets to try and eliminate 
human error. 
Other studies to evaluate laboratories separately could also be useful in training 
purposes, especially if it was found that specific laboratories had faster or slower report 
times. 
 Full automation of ELR systems with real time reporting should be a goal for 
laboratories in Southern Nevada.  However, it is important to remember that some 
diseases, such as highly-contagious measles, are best reported by a physician picking up a 
phone because they are reportable with clinical identification by a physician, which is the 
case in Nevada for certain highly infectious diseases. Viral laboratory cultures can take 
weeks to produce results, which would make them useless in outbreak prevention (NAC 
441A, 2012).  
 Another way to investigate public health response timeliness is by using 
syndromic surveillance, rather than laboratory confirmation in communicable disease 
outbreaks. Syndromic surveillance is a preparedness measure that examines health 
indicators (such as disease symptoms) to determine whether there is a higher incidence of 
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symptoms of diseases that may lead to bigger clusters or outbreaks. It is often used in 
hospital emergency departments (EDs), and is a part of the Meaningful Use regulations 
(CDC, 2012b).  
Researchers working with the NYC DOHMH conducted a syndromic surveillance 
study in EDs. They were able to show that symptoms were signals of outbreaks; 64% of 
respiratory signals and 95% of fever signals coincided with high incidence of influenza A 
and B (Heffernan et al. 2004). In addition, they found that 83% of diarrhea signals and 
88% of vomiting signals coincided with suspected outbreaks of norovirus and rotavirus 
infections (Heffernan et al. 2004).  
 It could be beneficial to incorporate more syndromic surveillance activity into 
disease surveillance in Southern Nevada to increase report time, in general. However, the 
downside to syndromic surveillance is that while it may help to prevent outbreaks, only 
laboratory tests can determine exactly what the disease is. 
 
Conclusions 
 The results of this study were somewhat inconclusive with regard to whether or 
not ELR is actually faster than traditional laboratory reporting. However, it is obvious 
that response time from laboratories is too long when health authorities are dealing with 
potential outbreaks. Testing methods of diseases can contribute to this, as can the fact that 
ELR is not fully automated with real time reporting in Southern Nevada, so human error 
may play a part in slow report times. In addition, standardized code sets are being 
implemented, but are not fully in place in Southern Nevada laboratories. 
 More studies of ELR would be greatly beneficial in Southern Nevada. Further 
studies to include more diseases, to evaluate human error, and to examine more aspects of 
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ELR such as accuracy and completeness of reports would likely benefit SNHD and the 
laboratories in Clark County. The report times are not fast enough, and more studies to 
determine why need to be conducted. 


























Dataset prepared for Jennifer Lucas 
Compiled by Brian Labus, Senior Epidemiologist 
 
This dataset was prepared for Jennifer Lucas in response to a data request made to the 
Southern Nevada Health District on April 25, 2012. The data provided have been produced in 
accordance with NRS 441A.220 and HIPAA, and contain no information that could be used 
individually or combined with other information to identify an individual patient. All elements of 
dates have been provided as a difference between two dates, or in the case of the year 
reported, the month and year of the report.  
 
Field Name Type Description 
disease_name Text The name of the disease (Campylobacteriosis, 
Giardiasis, Salmonellosis, Shigellosis) 
test_to_report Integer The number of days between the date of the 
laboratory test result and the date the test was 
reported to the health department 
onset_to_report Integer The number of days between the reported onset of 
disease and the date the disease was reported to the 
health department 
report_year Long Integer The month and year in which the case was reported, 
in the format of YYYYMM 
 
Recodes 
Field Name Type Description Recode_Name Recode_Description 











The month and year in 
which the case was 
reported, in the format of 
YYYYMM 










































Acquired immune deficiency syndrome 
Analysis of variance 
American Recovery and Reinvestment Act 
Centers for Disease Control and Prevention 
Confidence Interval 
Council of State and Territorial Epidemiologists 
Day(s) 
Direct fluorescent antibody 
Emergency Department 
Electronic laboratory reporting 
Electronic medical record 
Florida Department of Health 
Gastrointestinal 
Health information technology 
Health Information Technology for Economic and Clinical Health 
Human immunodeficiency virus 
Honestly significant difference 
Mean 
Nevada Administrative Code 
Nationally Notifiable Diseases Surveillance System 
Nevada Revised Statute 
New York City Department of Mental Health and Hygiene 
Ova and Parasite 
Office of Epidemiology 
Polymerase chain reaction 
Regenstrief Medical Record System 
Respiratory Syncytial Virus  
Standard Deviation 







Case Definitions  
Note: Definitions are reported verbatim from the public document, 2012 Case 
Definitions: Nationally Notifiable Diseases and Conditions and Current Case Definitions 
from the Centers for Disease Control and Prevention. 
(http://wwwn.cdc.gov/nndss/document/2012_Case%20Definitions.pdf) 
Campylobacteriosis (Campylobacter spp.)  
2012 Case Definition  
CSTE Position Statement Number: 11-ID-10  
Clinical Description  
A diarrheal illness of variable severity.  
 
Laboratory Criteria for Diagnosis  
Suspected  
Detection of Campylobacter spp. in a clinical specimen using non-culture based 
laboratory methods.  
 
Confirmed  
Isolation of Campylobacter spp. in a clinical specimen.  
 
Case Classification  
Suspected  
A case that meets the suspect laboratory criteria for diagnosis.  
 
Probable  




A case that meets the confirmed laboratory criteria for diagnosis.  
 
Comment  
The use of culture independent methods as standalone tests for the direct detection of 
Campylobacter in stool appears to be increasing. Data available about the performance 
characteristics of these assays indicates there is variability in the sensitivity, specificity 
and positive predictive value of these assays depending on the test (enzyme immunoassay 
(EIA) test format -lateral flow or –microplate) and manufacturer. It is therefore useful to 
collect information on which type of EIA test and manufacturer are used to diagnose a 








2011 Case Definition  
CSTE Position Statement Number: 10-ID-17  
 
Clinical Description  
An illness caused by the protozoan Giardia lamblia (aka G. intestinalis or G. duodenalis) 
and characterized by gastrointestinal symptoms such as diarrhea, abdominal cramps, 
bloating, weight loss, or malabsorption.  
 
Laboratory Criteria for Diagnosis  
Laboratory-confirmed giardiasis shall be defined as the detection of Giardia organisms, 
antigen, or DNA in stool, intestinal fluid, tissue samples, biopsy specimens or other 
biological sample.  
 
Case Classification  
Confirmed  
A case that meets the clinical description and the criteria for laboratory confirmation as 
described above. When available, molecular characterization (e.g., assemblage 
designation) should be reported.  
 
Probable  





Salmonellosis (Salmonella spp.)  
2012 Case Definition  
CSTE Position Statement Number: 11-ID-08  
 
Clinical Description  
An illness of variable severity commonly manifested by diarrhea, abdominal pain, 
nausea, and sometimes vomiting. Asymptomatic infections may occur, and the organism 
may cause extraintestinal infections.  
 
Laboratory Criteria for Diagnosis  
Suspect  
Detection of Salmonella from a clinical specimen using a non-culture based method  
 
Confirmed  
Isolation of Salmonella from a clinical specimen  
 
 
Case Classification  
Suspect  





A clinically compatible case that is epidemiologically linked to a confirmed case, i.e., a 
contact of a confirmed case or member of a risk group as defined by public health 
authorities during an outbreak.  
 
Confirmed  
A case that meets the confirmed laboratory criteria for diagnosis. When available, O and 
H antigen serotype characterization should be reported.  
 
Comment  
Both asymptomatic infections and infections at sites other than the gastrointestinal tract, 
if laboratory confirmed, are considered confirmed cases that should be reported. 
 
 
Shigellosis (Shigella spp.)  
2012 Case Definition  
CSTE Position Statement Number: 11-ID-19  
 
Clinical Description  
An illness of variable severity characterized by diarrhea, fever, nausea, cramps, and 
tenesmus. Asymptomatic infections may occur.  
 
Laboratory Criteria for Diagnosis  
Suspect  
Detection of Shigella from a clinical specimen using a non-culture based method.  
 
Confirmed  
Isolation of Shigella from a clinical specimen.  
 
Case Classification  
Suspect  
A case that meets the suspect laboratory criteria for diagnosis.  
 
Probable  
A clinically compatible case that is epidemiologically linked, i.e., is a contact of a 




A case that meets the confirmed laboratory criteria for diagnosis. When available, O 
antigen serotype characterization should be reported.  
 
Comment  
Both asymptomatic infections and infections at sites other than the gastrointestinal tract, 
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